| Year |
Citation |
Score |
| 2012 |
Brickey WJ, Neuringer IP, Walton W, Hua X, Wang EY, Jha S, Sempowski GD, Yang X, Kirby SL, Tilley SL, Ting JP. MyD88 provides a protective role in long-term radiation-induced lung injury. International Journal of Radiation Biology. 88: 335-47. PMID 22248128 DOI: 10.3109/09553002.2012.652723 |
0.546 |
|
| 2011 |
Hatada S, Walton W, Hatada T, Wofford A, Fox R, Liu N, Lill MC, Fair JH, Kirby SL, Smithies O. Therapeutic benefits in thalassemic mice transplanted with long-term-cultured bone marrow cells. Experimental Hematology. 39: 375-83, 383.e1-4. PMID 21184801 DOI: 10.1016/J.Exphem.2010.12.007 |
0.435 |
|
| 2011 |
Yang X, Walton W, Cook DN, Hua X, Tilley S, Haskell CA, Horuk R, Blackstock AW, Kirby SL. The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology. 45: 127-35. PMID 20870892 DOI: 10.1165/Rcmb.2010-0265Oc |
0.553 |
|
| 2007 |
Wang H, Gilner JB, Bautch VL, Wang DZ, Wainwright BJ, Kirby SL, Patterson C. Wnt2 coordinates the commitment of mesoderm to hematopoietic, endothelial, and cardiac lineages in embryoid bodies. The Journal of Biological Chemistry. 282: 782-91. PMID 17098737 DOI: 10.1074/Jbc.M606610200 |
0.693 |
|
| 2007 |
Gilner JB, Walton WG, Gush K, Kirby SL. Antibodies to stem cell marker antigens reduce engraftment of hematopoietic stem cells. Stem Cells (Dayton, Ohio). 25: 279-88. PMID 17008427 DOI: 10.1634/Stemcells.2006-0076 |
0.469 |
|
| 2005 |
Gabriel DA, Shea TC, Serody JS, Moore DT, Kirby SL, Harvey D, Krasnov C. Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 1022-30. PMID 16338625 DOI: 10.1016/J.Bbmt.2005.08.033 |
0.353 |
|
| 2004 |
Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K, Blazar BR, Serody JS. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. Journal of Immunology (Baltimore, Md. : 1950). 173: 845-54. PMID 15240671 DOI: 10.4049/Jimmunol.173.2.845 |
0.4 |
|
| 2004 |
Bushman J, Ciavatta D, Smithies O, Kirby S. TRANSGENE-INDUCED ENHANCEMENT OF HEMATO-VASCULAR DIFFERENTIATION FROM MURINE EMBRYONIC STEM CELLS Cardiovascular Pathology. 13: 23. DOI: 10.1016/J.Carpath.2004.03.061 |
0.498 |
|
| 2000 |
Hatada S, Nikkuni K, Bentley SA, Kirby S, Smithies O. Gene correction in hematopoietic progenitor cells by homologous recombination. Proceedings of the National Academy of Sciences of the United States of America. 97: 13807-11. PMID 11087825 DOI: 10.1073/Pnas.240462897 |
0.485 |
|
| 2000 |
Serody JS, Sparks SD, Lin Y, Capel EJ, Bigelow SH, Kirby SL, Gabriel DA, Wiley JM, Brecher ME, Schell MJ, Folds J, Shea TC. Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 6: 434-40. PMID 10975512 DOI: 10.1016/S1083-8791(00)70035-8 |
0.378 |
|
| 2000 |
Kirby S, Walton W, Smithies O. Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation. Blood. 95: 3710-5. PMID 10845901 DOI: 10.1182/Blood.V95.12.3710.012K38_3710_3715 |
0.484 |
|
| 1999 |
Kirby SL. Bone marrow: target for gene transfer. Hospital Practice. 34: 59-76. PMID 10611899 DOI: 10.3810/Hp.1999.12.176 |
0.502 |
|
| 1999 |
Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Murine T Lymphocytes Incapable of Producing Macrophage Inhibitory Protein-1 Are Impaired in Causing Graft-Versus-Host Disease Across a Class I But Not Class II Major Histocompatibility Complex Barrier Blood. 93: 43-50. DOI: 10.1182/Blood.V93.1.43 |
0.346 |
|
| 1996 |
Kirby SL, Cook DN, Walton W, Smithies O. Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene. Proceedings of the National Academy of Sciences of the United States of America. 93: 9402-7. PMID 8790342 DOI: 10.1073/Pnas.93.18.9402 |
0.55 |
|
| 1995 |
Yang B, Kirby S, Lewis J, Detloff PJ, Maeda N, Smithies O. A mouse model for beta 0-thalassemia. Proceedings of the National Academy of Sciences of the United States of America. 92: 11608-12. PMID 8524813 DOI: 10.1073/Pnas.92.25.11608 |
0.332 |
|
| 1991 |
Kirby SL, Bentley SA. Xyloside effects on in vitro hematopoiesis: Functional and biochemical studies Journal of Cellular Physiology. 148: 116-123. PMID 1860891 DOI: 10.1002/Jcp.1041480114 |
0.495 |
|
| 1990 |
Bentley SA, Kirby SL, Anklesaria P, Greenberger JS. Biochemical and functional characterization of proteoglycans produced by SI/SId murine bone marrow stromal cell lines Journal of Cellular Physiology. 145: 53-59. PMID 2211843 DOI: 10.1002/Jcp.1041450109 |
0.4 |
|
| 1989 |
Bentley SA, Kirby SL. Biosynthesis of proteochondroitin sulfate by HL-60 human promyelocytic cells. Journal of Leukocyte Biology. 45: 46-54. PMID 2911020 DOI: 10.1002/Jlb.45.1.46 |
0.427 |
|
| 1988 |
Bentley SA, Kirby SL, Anklesaria P, Greenberger JS. Bone marrow stromal proteoglycan heterogeneity: phenotypic variability between cell lines and the effects of glucocorticoid. Journal of Cellular Physiology. 136: 182-187. PMID 3397395 DOI: 10.1002/Jcp.1041360124 |
0.408 |
|
| 1987 |
Kirby S, Bentley S. Proteoglycan synthesis in two murine bone marrow stromal cell lines Blood. 70: 1777-1783. DOI: 10.1182/Blood.V70.6.1777.1777 |
0.417 |
|
| Show low-probability matches. |